© 2019 by Biohaven Pharmaceuticals. For more information about Biohaven Pharmaceuticals visit the Biohaven website.

  • Facebook
  • Twitter
  • YouTube
  • LinkedIn
  • Instagram

SCA Study: Why Participate?


By joining this clinical study for Spinocerebellar ataxia (SCA), you will help contribute to our understanding of this disease and potential treatments. You will also receive:

‚Äč

  • Study related evaluations of your SCA symptoms and overall health.

  • Investigational medication and study related care at no cost.

  • You may receive compensation for your participation and travel related expenses.

Current Treatment and Research

  • There is no cure or FDA approved treatment to delay or halt the progression of SCA.

  • Current treatment approaches include therapeutic strategies to help manage symptoms to improve quality of life.

  • There are few clinical trials researching new treatment options.